1. 392 Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: subgroup analysis by risk in the phase III solo1 study. (4th December 2020) Authors: Colombo, Nicoletta; Bradley, William; Moore, Kathleen; González-Martín, Antonio; Scambia, Giovanni; Oaknin, Ana; Friedlander, Michael; Lowe, Elizabeth; Rowe, Phil; Disilvestro, Paul Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Olaparib Tablets as Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a BRCA1/2 Mutation (SOLO2/ENGOT-Ov21): A Final Analysis of a Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial. Issue 9 (September 2021) Authors: Poveda, Andrés; Floquet, Anne; Ledermann, Jonathan A.; Asher, Rebecca; Penson, Richard T.; Oza, Amit M.; Korach, Jacob; Huzarski, Tomasz; Pignata, Sandro; Friedlander, Michael; Baldoni, Alessandra; Park-Simon, Tjoung-Won; Tamura, Kenji; Sonke, Gabe S.; Lisyanskaya, Alla; Kim, Jae-Hoon; Filho, Eli... Journal: Obstetrical & gynecological survey Issue: Volume 76:Issue 9(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Olaparib Tablets as Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a BRCA1/2 Mutation (SOLO2/ENGOT-Ov21): A Final Analysis of a Double-Blind, Randomised, Placebo-Controlled, Phase 3 Trial. Issue 9 (September 2021) Authors: Poveda, Andrés; Floquet, Anne; Ledermann, Jonathan A.; Asher, Rebecca; Penson, Richard T.; Oza, Amit M.; Korach, Jacob; Huzarski, Tomasz; Pignata, Sandro; Friedlander, Michael; Baldoni, Alessandra; Park-Simon, Tjoung-Won; Tamura, Kenji; Sonke, Gabe S.; Lisyanskaya, Alla; Kim, Jae-Hoon; Filho, Eli... Journal: Obstetrical & gynecological survey Issue: Volume 76:Issue 9(2021) Page Start: 535 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 5 (May 2021) Authors: Poveda, Andrés; Floquet, Anne; Ledermann, Jonathan A; Asher, Rebecca; Penson, Richard T; Oza, Amit M; Korach, Jacob; Huzarski, Tomasz; Pignata, Sandro; Friedlander, Michael; Baldoni, Alessandra; Park-Simon, Tjoung-Won; Tamura, Kenji; Sonke, Gabe S; Lisyanskaya, Alla; Kim, Jae-Hoon; Filho, Elias A... Journal: Lancet oncology Issue: Volume 22:Issue 5(2021) Page Start: 620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial. Issue 12 (December 2017) Authors: Bang, Yung-Jue; Xu, Rui-Hua; Chin, Keisho; Lee, Keun-Wook; Park, Se Hoon; Rha, Sun Young; Shen, Lin; Qin, Shukui; Xu, Nong; Im, Seock-Ah; Locker, Gershon; Rowe, Phil; Shi, Xiaojin; Hodgson, Darren; Liu, Yu-Zhen; Boku, Narikazu Journal: Lancet oncology Issue: Volume 18:Issue 12(2017:Dec.) Page Start: 1637 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗